scispace - formally typeset
Search or ask a question
Institution

University of Nigeria, Nsukka

EducationNsukka, Nigeria
About: University of Nigeria, Nsukka is a education organization based out in Nsukka, Nigeria. It is known for research contribution in the topics: Population & Health care. The organization has 10211 authors who have published 13685 publications receiving 138922 citations.
Topics: Population, Health care, Public health, Malaria, Igbo


Papers
More filters
Journal ArticleDOI
TL;DR: In this paper, the authors surveyed the vocational developmental pattern of Nigerian students using the Career Maturity Inventory (Crites), and their results and their applicability to the Nigerian situation were discussed.

47 citations

Journal ArticleDOI
TL;DR: In this paper, the influence of corporate board characteristics on environmental disclosure quantity of listed firms in two leading emerging economies: South Africa and Nigeria which practice i.i.d. environmental disclosure.
Abstract: The study examined the influence of corporate board characteristics on environmental disclosure quantity of listed firms in two leading emerging economies: South Africa and Nigeria which practice i...

47 citations

Journal ArticleDOI
TL;DR: A total of 2,570 apparently healthy human immunodeficiency virus-negative adults from the six geopolitical zones in the country were enrolled in this study in 2006 and had CD4 counts within the range of 501 to 1,000 cells/μl.
Abstract: A total of 2,570 apparently healthy human immunodeficiency virus-negative adults from the six geopolitical zones in the country were enrolled in our study in 2006. The samples were assayed using the Cyflow technique. Data were analyzed using the Statistical Package for Social Scientists (SPSS). The majority (64%) of the participants had CD4 counts within the range of 501 to 1,000 cells/μl. The reference range for CD4 was 365 to 1,571 cells/μl, while the reference range for CD8 was 145 to 884 cells/μl.

47 citations

Journal ArticleDOI
TL;DR: The results support the safety of IRAB in HIV/AIDS, and its significant influence on CD4+ cells may be useful in the formulation of multidrug combination therapies for HIV/ AIDS, however, its antiretroviral activity is being evaluated in the laboratory.
Abstract: The safety and effect of an acetone-water neem leaf extract (IRAB) on CD4 cells was investigated in 60 HIV/AIDS patients as part of an ongoing study to determine the influence of neem on immunity and viral load in HIV/AIDS. Patients were confirmed as HIV I or II positive, as having CD4 cell count, less than 300 cells/microL, and as antiretrovirally naive. They were given oral IRAB (1.0 g daily for 12 weeks). Clinical and laboratory tests were carried out at baseline and at 4 weekly intervals. Thus, the patients served as their own controls. Sixty patients completed treatment. Fifty (83.33%) were completely compliant with respect to laboratory tests. Increase in mean CD4 cells, 266 cells/microL (159%), for the 50 patients was significant (P < 0.001) between baseline and week 12. Erythrocyte sedimentation rate (64 mm/hr at baseline) was 16 mm/hr at week 12, whereas total number of incidences of HIV/AIDS-related pathologies decreased from 120 at baseline to 5. Mean bodyweight, hemoglobin concentration, and lymphocyte differential count increased significantly by 12% (P < 0.05), 24% (P < 0.0001), and 20% (P < 0.0001), respectively. There were no adverse effects and no abnormalities in kidney and liver function parameters. The results support the safety of IRAB in HIV/AIDS, and its significant influence on CD4 cells may be useful in the formulation of multidrug combination therapies for HIV/AIDS. However, its antiretroviral activity is being evaluated in our laboratory.

47 citations

Journal ArticleDOI
TL;DR: It is necessary to provide awareness campaigns, health education, proper screening of blood and blood products for transfusion, active screening, intensification of existing childhood immunization, technical and financial assistance from wealthier nations, and implementation of the recommendations outlined in the Global Hepatitis Policy (2010).
Abstract: Sylvester Chuks Nwokediuko, Department of Medicine, University of Nigeria Teaching Hospital, Ituku OzallaChronic infection with hepatitis B virus (HBV) is a global public health problem because of its worldwide distribution and its potential to cause sequelae. HBV is most prevalent in China, South East Asia, sub-Saharan Africa, and the Amazon basin of South America where health care resources are most limited. Numerous challenges exist for effective management of chronic HBV infection, particularly in resource-limited regions. These challenges include lack of accurate prevalence data, absence of a surveillance program, and poor political will of governments in resource-poor countries to enforce effective measures to control the disease. There is a lack of understanding regarding HBV infec-tion by both the general public and health care providers. A better understanding of the pathogenesis and treatment of this condition is necessary. The acute shortage of trained medical manpower necessary for accurate diagnosis and treatment of chronic hepati-tis B (CHB) in resource-poor countries is a formidable challenge. The condition is com-plicated by the continuing efflux of medical graduates from low-income economies to richer countries. The most critical problem in the management of CHB is the high cost of laboratory tests and drugs. Drugs are also not readily available. Other challenges in the manage-ment of CHB include stigmatization of patients, co-infection with other viruses, lack of management guidelines, and absence of an effective patient referral system. To address these challenges, governments of resource-poor nations must be committed to budg-etary allocation for the implementation of health programs. It is necessary to provide awareness campaigns, health education, proper screening of blood and blood products for transfusion, active screening, intensification of existing childhood immunization, technical and financial assistance from wealthier nations, and implementation of the recommendations outlined in the Global Hepatitis Policy (2010).

47 citations


Authors

Showing all 10333 results

NameH-indexPapersCitations
Kamyar Kalantar-Zadeh118102556187
Peter J. Houghton6322814321
Alessandro Piccolo6228414332
R. W. Guillery6010613439
Ulrich Klotz5621310774
Nicholas H. Oberlies522629683
Brian Norton493229251
Adesola Ogunniyi4727211806
Obinna Onwujekwe432828960
Sanjay Batra393297179
Benjamin Uzochukwu381639318
Christian N. Madu361345378
Jude U. Ohaeri361213088
Peter A. Akah331643422
Charles E. Chidume331533639
Network Information
Related Institutions (5)
University of Ibadan
18.8K papers, 330.6K citations

93% related

Makerere University
12.4K papers, 366.5K citations

88% related

College of Health Sciences, Bahrain
22.3K papers, 400.2K citations

88% related

United Arab Emirates University
14.1K papers, 321.1K citations

87% related

Addis Ababa University
10.2K papers, 264.8K citations

87% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202360
2022129
20211,654
20201,560
20191,191
2018884